229 related articles for article (PubMed ID: 38090580)
1. Research progress on the mechanism of glycolysis in ovarian cancer.
Li C; Liu FY; Shen Y; Tian Y; Han FJ
Front Immunol; 2023; 14():1284853. PubMed ID: 38090580
[TBL] [Abstract][Full Text] [Related]
2. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
Zeng L; Zhou HY; Tang NN; Zhang WF; He GJ; Hao B; Feng YD; Zhu H
World J Gastroenterol; 2016 May; 22(20):4868-80. PubMed ID: 27239113
[TBL] [Abstract][Full Text] [Related]
3. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer.
Gao T; Zhang X; Zhao J; Zhou F; Wang Y; Zhao Z; Xing J; Chen B; Li J; Liu S
Cancer Lett; 2020 Jan; 469():89-101. PubMed ID: 31639424
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of aerobic glycolysis in breast cancer.
Wu Z; Wu J; Zhao Q; Fu S; Jin J
Clin Transl Oncol; 2020 May; 22(5):631-646. PubMed ID: 31359335
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circRHOBTB3 inhibits ovarian cancer progression through PI3K/AKT signaling pathway.
Sun Y; Liu Y; Chen H; Tan Y
Panminerva Med; 2024 Mar; 66(1):36-46. PubMed ID: 32720791
[TBL] [Abstract][Full Text] [Related]
6. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K.
Courtnay R; Ngo DC; Malik N; Ververis K; Tortorella SM; Karagiannis TC
Mol Biol Rep; 2015 Apr; 42(4):841-51. PubMed ID: 25689954
[TBL] [Abstract][Full Text] [Related]
7. Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells - A potential contribution to the predictive, preventive, and personalized medicine.
Mazurakova A; Koklesova L; Csizmár SH; Samec M; Brockmueller A; Šudomová M; Biringer K; Kudela E; Pec M; Samuel SM; Kassayova M; Hassan STS; Smejkal K; Shakibaei M; Büsselberg D; Saso L; Kubatka P; Golubnitschaja O
J Adv Res; 2024 Jan; 55():103-118. PubMed ID: 36871616
[TBL] [Abstract][Full Text] [Related]
8. Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas.
Vallée A; Guillevin R; Vallée JN
Rev Neurosci; 2018 Jan; 29(1):71-91. PubMed ID: 28822229
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
[TBL] [Abstract][Full Text] [Related]
10. ACTL6A regulates follicle-stimulating hormone-driven glycolysis in ovarian cancer cells via PGK1.
Zhang J; Zhang J; Wei Y; Li Q; Wang Q
Cell Death Dis; 2019 Oct; 10(11):811. PubMed ID: 31649264
[TBL] [Abstract][Full Text] [Related]
11. Metabolic phenotype of bladder cancer.
Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
[TBL] [Abstract][Full Text] [Related]
12. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
13. ITGB2 fosters the cancerous characteristics of ovarian cancer cells through its role in mitochondrial glycolysis transformation.
Li GW; Jin YP; Qiu JP; Lu XF
Aging (Albany NY); 2024 Feb; 16(3):3007-3020. PubMed ID: 38345576
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
Rodríguez-García A; Samsó P; Fontova P; Simon-Molas H; Manzano A; Castaño E; Rosa JL; Martinez-Outshoorn U; Ventura F; Navarro-Sabaté À; Bartrons R
FEBS J; 2017 Oct; 284(20):3437-3454. PubMed ID: 28834297
[TBL] [Abstract][Full Text] [Related]
15. PGAM1 Promotes Glycolytic Metabolism and Paclitaxel Resistance via Pyruvic Acid Production in Ovarian Cancer Cells.
Feng Y; Zhang X; Zhang S; Xu S; Chen X; Zhou C; Xi Y; Xie X; Lu W
Front Biosci (Landmark Ed); 2022 Sep; 27(9):262. PubMed ID: 36224008
[TBL] [Abstract][Full Text] [Related]
16. Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells.
Fukushi A; Kim HD; Chang YC; Kim CH
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077431
[TBL] [Abstract][Full Text] [Related]
17. Revisiting the Warburg effect: historical dogma versus current understanding.
Vaupel P; Multhoff G
J Physiol; 2021 Mar; 599(6):1745-1757. PubMed ID: 33347611
[TBL] [Abstract][Full Text] [Related]
18. Silencing of FGF6 hampers aerobic glycolysis and angiogenesis in bladder cancer by regulating PI3K/Akt and MAPK signaling pathways.
Zhi Y; Cai C; Xu T; Sun F; Wang KP; Ji Z; Pei Y; Geng S; Wang H
J Biochem Mol Toxicol; 2023 Aug; 37(8):e23399. PubMed ID: 37345681
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-124 suppresses proliferation and glycolysis in non-small cell lung cancer cells by targeting AKT-GLUT1/HKII.
Zhao X; Lu C; Chu W; Zhang B; Zhen Q; Wang R; Zhang Y; Li Z; Lv B; Li H; Liu J
Tumour Biol; 2017 May; 39(5):1010428317706215. PubMed ID: 28488541
[TBL] [Abstract][Full Text] [Related]
20. A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axis.
Yang X; Cheng Y; Li P; Tao J; Deng X; Zhang X; Gu M; Lu Q; Yin C
Tumour Biol; 2015 Jan; 36(1):383-91. PubMed ID: 25266796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
